| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CALL FOR PAPERS
Metabolic Syndrome
Center for Interdisciplinary Research in Cardiovascular Sciences, Department of Physiology and Pharmacology, West Virginia University, School of Medicine, Morgantown, West Virginia
Submitted 16 February 2005 ; accepted in final form 29 March 2005
This study tested the hypothesis that chronically elevated oxidant stress contributes to impaired active hyperemia in skeletal muscle of obese Zucker rats (OZR) vs. lean Zucker rats (LZR) through progressive deteriorations in microvascular structure. Twelve-week-old LZR and OZR were given 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (tempol) in the drinking water for 
4 wk. Subsequently, perfusion of in situ gastrocnemius muscle was determined during incremental elevations in metabolic demand, while a contralateral skeletal muscle arteriole and the gastrocnemius muscle was removed to determine dilator reactivity, vessel wall mechanics, and microvessel density. Under control conditions, active hyperemia was impaired at all levels of metabolic demand in OZR, and this was correlated with a reduced microvessel density, increased arteriolar stiffness, and impaired dilator reactivity. Chronic tempol ingestion improved perfusion during moderate to high metabolic demand only and was associated with improved arteriolar reactivity and microvessel density; passive vessel mechanics were unaltered. Combined antioxidant therapy and nitric oxide synthase inhibition in OZR prevented much of the restored perfusion and microvessel density. In LZR, treatment with N
-nitro-L-arginine methyl ester (L-NAME) hydrochloride and hydralazine (to prevent hypertension) impaired active hyperemia, dilator reactivity, and microvessel density, although arteriolar distensibility was not altered. These results suggest that with the development of the metabolic syndrome, chronic reductions in nitric oxide bioavailability, in part via the scavenging actions of oxidative free radicals, contribute to a loss of skeletal muscle microvessels, leading to impaired muscle perfusion with elevated metabolic demand.
microcirculation; regulation of skeletal muscle blood flow; functional hyperemia; active hyperemia
This article has been cited by other articles:
|
|
 |
|
  M. A. Potenza, F. Addabbo, and M. Montagnani Vascular actions of insulin with implications for endothelial dysfunction Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E568 - E577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Zwetsloot, L. M. Westerkamp, B. F. Holmes, and T. P. Gavin AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise J. Physiol., December 15, 2008; 586(24): 6021 - 6035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Levy, E. L. Schiffrin, J.-J. Mourad, D. Agostini, E. Vicaut, M. E. Safar, and H. A.J. Struijker-Boudier Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus Circulation, August 26, 2008; 118(9): 968 - 976. [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hamburg, M. J. Keyes, M. G. Larson, R. S. Vasan, R. Schnabel, M. M. Pryde, G. F. Mitchell, J. Sheffy, J. A. Vita, and E. J. Benjamin Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study Circulation, May 13, 2008; 117(19): 2467 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, R. A. Redetzke, S. Said, J. V. Pottala, G. M. de Escobar, and A. M. Gerdes Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2137 - H2143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Lesniewski, A. J. Donato, B. J. Behnke, C. R. Woodman, M. H. Laughlin, C. A. Ray, and M. D. Delp Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1840 - H1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Jonk, A. J. H. M. Houben, R. T. de Jongh, E. H. Serne, N. C. Schaper, and C. D. A. Stehouwer Microvascular Dysfunction in Obesity: A Potential Mechanism in the Pathogenesis of Obesity-Associated Insulin Resistance and Hypertension Physiology, August 1, 2007; 22(4): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Sokolnicki, S. K. Roberts, B. W. Wilkins, A. Basu, and N. Charkoudian Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E314 - E318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Frisbee, J. B. Samora, J. Peterson, and R. Bryner Exercise training blunts microvascular rarefaction in the metabolic syndrome Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2483 - H2492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Stump, M. T. Hamilton, and J. R. Sowers Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus Mayo Clin. Proc., June 1, 2006; 81(6): 796 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Frisbee Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2066 - H2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. K. Johnson, R. A. Johnson, W. Durante, K. E. Jackson, B. K. Stevenson, and K. J. Peyton Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R601 - R608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Persson From clinical insights to new therapies Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R124 - R125. [Full Text] [PDF]
|
|
|
|
|
|
L. Xiang, J. S. Naik, B. L. Hodnett, and R. L. Hester Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R134 - R138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mather and S. Verma Function determines structure in the vasculature: lessons from insulin resistance Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R305 - R306. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
